Clarke, J. M., Simon, G. R., Mamdani, H., Gu, L., Herndon, J. E., Stinchcombe, T. E., . . . Patz, E. F. Complement factor H targeting antibody GT103 in refractory non-small cell lung cancer: A phase 1b dose escalation trial. Nature Portfolio.
Chicago Style (17th ed.) CitationClarke, Jeffrey M., et al. Complement Factor H Targeting Antibody GT103 in Refractory Non-small Cell Lung Cancer: A Phase 1b Dose Escalation Trial. Nature Portfolio.
MLA (9th ed.) CitationClarke, Jeffrey M., et al. Complement Factor H Targeting Antibody GT103 in Refractory Non-small Cell Lung Cancer: A Phase 1b Dose Escalation Trial. Nature Portfolio.
Warning: These citations may not always be 100% accurate.